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Abstract
Background: In the past, the relationship between coronary artery disease (CAD) and
blood group type has been studied extensively. The ABO blood group has a significant
effect on homeostasis and is therefore associated with adverse cardiovascular events.
This study aimed to determine the distribution of ABO blood group and rhesus (Rh)
status (ABO/Rh) in patients with different severity of CAD in Iranian community.
Material and Methods: A total of 1,236 CAD patients undergoing angiography were
evaluated and their ABO/Rh blood type was determined in a study center between
February 2005 and December 2010. Of the 1,236 records, only 1,046 medical
documents recorded the number of involved vessels. The patients were classified
according to the number of significantly affected stenotic vessels into single vessel
(1VD), two vessels (2VD), and three vessels (3VD) disease subgroups.
Results: A substantially different ABO/Rh blood groups distribution was seen in the
examined samples (O: 29.7%, A: 39.7%, B: 22.2%, AB: 8.3%, Rh positivity: 89.2%). The
ABO/Rh blood group phenotype distribution in CAD patients with 1VD, 2VD, and 3VD
was as follows: 37.5%, 41.3%, and 41.5%, respectively, for group A; 24.1%, 20.5%, and
20.6%, respectively, for group B; 31.2%, 26.8%, and 30.2%, respectively, for group O;
7.1%, 11.4% and 7.7%, respectively, for group AB (p = 0.26), and 88.7%, 90.5%, and 87.6%,
respectively, for Rh positivity, (p = 0.47).
Conclusions: No significant correlation was not found among the ABO/Rh blood group
distribution and the number of vessels involved, however, according to the different
distribution of ABO/Rh blood group in CAD patients and healthy population, ABO/Rh
might have an unknown role in CAD patients.
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1. Introduction
The ABO blood group system was first described by Karl Landsteiner in 1901 [1].
It consists of three alleles: A and B (co-dominant) and O (recessive) [2, 3]. Each A
and B allele encodes glycosyltransferases that add the N-acetylgalactosamine and D-
galactose to precursor H antigen and convert it to A and B antigen. While O does
not encode any transferase enzyme, the H antigen is expressed unchanged in this
group [4]. The ABO antigens [3] are not only present at the surface of red blood cells
(RBCs) but are also widely expressed in a number of human tissues and cells, including
sensory neurons, the epithelium, the vascular endothelium and platelets [3]. A number of
experimental and clinical studies have evaluated whether the ABO blood group could
affect the traditional risk factors of arterial or venous thrombotic events [5]. Several
reports have indicated a specified relationship among non-O blood groups, and the risk
of progressing severe manifestations of atherosclerosis [6–8]. Atherosclerosis is one of
the major causes of adults’ death in numerus countries. Atherosclerotic developmental
risk factors provide useful ways to prevent coronary artery disease (CAD) [9]. Gender,
obesity, smoking, age, hypertension, diabetesmellitus, and family history are considered
as main cardiovascular risk factors [10]. One of the recently published cohort articles of
BMCMedicine evaluated over 50,000 subjects and demonstrated that almost 6% of total
death and 9% of cardiovascular death have non-O blood groups [11]. In addition, some
studies have suggested that in A blood group subjects, the incidence of ischemic heart
disease may be higher than other blood groups [7, 12]. On the other hand, Amirzadegan
et al. reported that there is not association between different ABO blood types and the
development of CAD in Iranian population [13]. So, the present study aimed to determine
the distribution of ABO blood group and rhesus (Rh) status (ABO/Rh) in patients with
different severity of CAD in Iranian community.
2. Methods
2.1. Study design and population
In this retrospective study, medical documents of 1,236 CAD patients (with documents
that showed cardiac disease or suspected for poss it) hospitalized at the Department of
Cardiology, Urmia University of Medical Sciences (UMSU), Urmia, Iran between February
2005 and December 2010 were reviewed. Coronary angiography and determination
of ABO/Rh blood group were performed for all patients. Subjects were classified into
four groups according to the different blood types and two groups according to the Rh
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types, respectively: AB-type group, A-type group, B-type group, and O-type blood group
and Rh-positive and Rh-negative groups. Further analysis was performed between O
type and non-O type. All clinical and demographic data were prepared in the dedicated
cardiovascular database. Smoking habits, hypertension, diabetes mellitus, hypercholes-
terolemia, and renal disorders were recorded. However, of the 1,236 CAD records, only
1,046 medical documents recorded severity of stenosis. Next, according to the results
of the angiography, the subjects with stenosis in at least one major coronary artery
were classified into three subgroups depending on the number of diseased vessels:
patients with single-vessel (1VD), two-vessels (2VD), and three-vessels (3VD) disease
subgroups. This research agrees with current ethical considerations and was approved
by the Medical Ethics Committee of UMSU.
2.2. Statistical analysis
Data were analyzed using the SPSS version 18. Fisher’s exact test, Chi-square test, and
one way-ANOVA were used to analyze the data from different disease groups. P-value
< 0.05 was considered to be statistically significant.
3. Results
A total of 1,236 medical documents of CAD patients were reviewed. Table 1 presents
the gender, smoking habit, history of diabetes mellitus, hypertension, hyperlipidemia,
TABLE 1: The relation of ABO/Rh blood group distribution with demographics and characteristics of coronary
artery disease patients.
Blood Groups Rh Status
A B AB O Non-O
blood
P‡ P¶ Rh+ Rh– P-value




















161/266 99/140 37/58 104/224 298/463 0.09 0.11 359/610 42/77 0.39
Diabetes
(+/–)*




0.30 0.04 195/757 19/91 0.25
Hypertension
(+/–)*
183/248 106/133 36/51 139/161 325/432 0.72 0.17 416/534 48/59 0.49
Hyperlipidemia
(+/–)*




13/450 8/255 0/96 11/334 21/802 0.38 0.33 29/1009 3/125 0.52
*Different number between groups in Table 1 is related to impaired medical documents records.
P‡: between different blood groups; P¶: between O and non-O blood groups
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and renal disorders based on the blood group distribution of these persons (p > 0.05).
Patients included 474 women (38.3%) and 762 (61.7%) men, with a mean age of 58.5 ±
11.4 years, of which 61.9% (401/648) were smokers. The mean age of all types of ABO
blood group in patients is demonstrated in Table 1. The age distribution among different
blood groups were alike in patient subgroups (p = 0.28). Only the prevalence of diabetes
was significantly different in 23.2% (142/612) patients with non-O blood group versus
30.9% (73/236) of patients with group O; Table 1 (p = 0.04).
As mentioned earlier, of the 1,236 CAD patient records, only in 1,046 medical doc-
uments had records of number of vessels involved with stenosis. Further, of the 1,046
CAD patients, 365 (34.9%) patients had 1VD, 317 (30.3%) had 2VD, and 364 (34.8%) had
stenosis in 3VD. Table 2 shows the ABO and Rh blood group distribution in 1VD, 2VD,
and 3VD patients (p = 0.26 and p = 0.47, respectively). Of note, no significant difference
was observed in the distribution of 1VD, 2Vd, and 3VD stenosis when the patients were
divided according to the presence of O and non-O blood groups; Table 2 (p = 0.42).
TABLE 2: Distribution of ABO/Rh blood group in the number of vessels involved in coronary artery disease
patients.
Blood Groups N (%) Rh Status
A B AB O Non-O blood
type
P‡ P¶ 1046 Rh+ Rh– P-value
1VD 137 88 26 114 251 365 (34.9%) 324 41
2VD 131 65 36 85 232 0.26 0.42 317 (30.3%) 287 30 0.47
3VD 151 75 28 110 253 364 (34.8%) 318 45
1VD = single vessel disease; 2VD = 2 vessels disease; 3VD = 3 vessels disease
P‡: between different blood groups; P¶: between O and non-O blood groups
4. Discussion
ABO blood groups are the most studied antigenic system of red blood cells and their
phenotypes are easily identified; they have been used as genetic markers in researches
of relationship with different diseases [14]. Unsurprisingly, the clinical significance of the
ABO blood group now develops beyond the traditional boundaries of immunohema-
tology and blood transfusion medicine, in which the antigen system appears to play a
role in the pathophysiology of most human diseases including cardiovascular disorders
[15, 16].
However, the association among ABO blood group and CAD in clinical practice is
unclear. Briancari et al. reported that ABO blood groups had a very similar distribution
between patients undergoing coronary artery bypass graft compared to the general
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population. The study also found that blood type B was associated with higher angio-
graphic scores, but postoperative complications did not differ between groups (17).
Moreover, the data from the official report of the local Blood Transfusion Center
showed the distribution of ABO/Rh groups in the Iranian people as follows: O: 34.7%, A:
33.7%, B: 20.7%, AB: 8.4%. Also, positive Rh was seen in 89.6% of the healthy population
[18]. The result of this study showed a diverse distribution in our evaluated population
(O: 29.7%, A: 39.7%, B: 22.2%, AB: 8.3%, and Rh+: 89.2%), which may be related to the
lower susceptibility of O blood group to CAD as presented in Table 3.
TABLE 3: Comparison of the ABO/Rh groups distribution between Iranian healthy population and CAD
patients
A B AB O Rh+
Iranian healthy population 33.7% 20.7% 8.4% 34.7% 89.6%
CAD patients 39.7% 22.2% 8.3% 29.7% 89.2%
Stakisaitis et al. found a relation between B blood group and coronary atherosclerosis
in Lithuanian women [19], which is not compliant with our study. Chen et al. [20] reported
that non-O group is associated with the presence of significant CAD indicated by >
50% stenosis in ≥ 1 coronary artery in angiography, however, we did not observe
any significant association between the O and non-O groups with CAD. Perhaps, this
contradiction is because the study type of these two investigations was different. Also,
they reported that there was no association between the ABO group and the number
(1 or 2 or 3) of coronary arteries with > 50% stenosis.
Omidi et al. [21] in Iran investigated the relationship between O and non-O groups
with severity of CAD and found that there is severe involvement among them.
A database of 1,236 patients undergoing coronary angiography were evaluated to
better understand the relation among CAD severity and ABO blood type. The authors
of this study analyzed the possible relationship between CAD severity and ABO blood
type, as well as its association with traditional atherosclerosis risk factors. Our data do
not support the major contribution of ABO blood system in severe CAD stenosis, and no
clinical outcome can be deduced from this data. For many years, the ABO blood group
has been related with a tendency to venous and arterial disorders including peripheral
vascular disease, CAD, and venous thromboembolism [7, 12, 22]. Non-O individuals have
a higher susceptibility to these conditions, which can be due to high levels of plasma
VIII factors and von-Willebrand factor [23]. In the majority of previous studies, patients
under study were known case of CAD, and this study could not find enough information
about ABO blood groups and severity of CAD. Therefore, this study’s investigators
designed a study on the ABO/Rh blood groups distribution in a series of patients who
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were diagnosed angiographically as CAD in order to evaluate whether ABO/Rh blood
groups are associated with the number of vessels involved as a risk of CAD severity.
According to the best of author’s knowledge, there is no other research in Iranian
society about the evaluation of ABO blood type and CAD severity.
5. Conclusion
In this study, no association was observed between the type of ABO blood groups
and the rate of coronary artery atherosclerotic lesions in Iranian patients with chronic
CAD. Also, no significant relationship between O-type blood and the number of vessels
involved as a risk of CAD severity was observed.
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